accacuteadherenceadministrationadultsadverseafraidahaamericanamonganalysisantiplateletaorticapixabanarterialarteryaspirinassociatedassociationatheroscleroticatrialbasedbenefitsbetableedingblockerblockersbloodbypasscardiaccardiogeniccardiomyopathycardiovascularcarotidcenterchronicclinicalclopidogrelcohortcombinationcombinedcomparedcomparisoncongresscontemporarycontrolledcoronarycriticallydaptdatadiabetesdirecteddiseasedrugdualearlyeffecteffectivenesseffectsefficacyejectionelevationendovascularesceventsfactorsfailurefibrillationfollowingfractionfunctiongraftingguidelineguidelineshbrhearthfhfpefhfrefhighhighlightshospitalhypertensionhypertrophicillimpactimprovesincidenceindividualinfarctioninhibitorinhibitorsinitiationinjuryinsightsinterventionischemickeyleftlevellongmajormanagementmatchedmedicalmellitusmetametoprololmildlymitralmoderatemonotherapymonthmortalitymultimyocardialobstructiveocclusionoraloutcomesp2y12patientpatientspcipediatricpercutaneousperipheralplateletpluspointspostpreservedpressurepreventionprimaryprognosticpropensityprospectivepulmonaryrandomizedrapidraterealreducedreductionregistryregurgitationremodelingrepairreperfusionresultsretrospectiverevascularizationreviewriskrivaroxabansafetyscoresecondarysegmentseveresexsglt2shockshortsinglesizestemistentingstillstrokestudysuccessfulsyndromesyndromessystematicsystemictargettermtherapyticagrelortitratetotaltranscathetertreatedtreatmenttreatmentstrialtrialstwilighttypeundergoingusevaluevalveventricularversuswithoutworldyoung